Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 1-14 , January 2010

Is Human Herpesvirus-8 Transmitted by Transfusion?

  • Eleftherios C. Vamvakas

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Eleftherios C. Vamvakas, MD, PhD, Pathology and Laboratory Medicine, South Tower, Rm # 3733, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048.

References 

  1. Cannon MJ, Laney AS, Pellett PE. Human herpesvirus 8: Current issues. Clin Infect Dis. 2003;37:82–87
  2. Blackbourn DJ, Ambroziak J, Lennette E, et al. Infectious human herpesvirus 8 in a healthy North-American blood donor. Lancet. 1997;349:609–611
  3. Vamvakas EC, Tegtmeier GE. Herpes viruses. In:  Barbara JAJ,  Regan FAM,  Contreras MC editor. Transfusion microbiology. Cambridge, UK: Cambridge University Press; 2008;p. 35–58
  4. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in South African patients with cancer. N Engl J Med. 1999;340:1863–1871
  5. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med. 1996;156:202–204
  6. Olsen SJ, Chang Y, Moore PS, et al. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS. 1998;12:1921–1925
  7. Elton MA, Mbulaiteye SM, Dada AJ, et al. Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. AIDS. 2002;16:2473–2478
  8. Cattani P, Cerimele F, Porta D, et al. Age-specific seroprevalence of human herpesvirus-8 in Mediterranean regions. Clin Microbiol Infect. 2008;9:274–279
  9. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence and Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol. 1998;1:207–213
  10. Zavitsanou A, Sypsa V, Petrodaskalaki M, et al. Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: Seroprevalence and associated factors. J Med Virol. 2007;79:591–596
  11. Iscovich J, Fischbein A, Fisher-Fischbein J, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res. 2000;20:2119–2122
  12. Gambus G, Bourboulia D, Esteve A, et al. Prevalence and distribution of HHV-8 in different subpopulations with and without HIV infection in Spain. AIDS. 2001;15:1167–1174
  13. Schinaia N, Kodra Y, Sarmati L, et al. Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. Eur J Epidemiol. 2004;19:467–469
  14. Challine D, Roudot-Troraval F, Sarah T, et al. Seroprevalence of human herpesvirus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion. 2001;41:1120–1125
  15. Pellett PE, Wright DJ, Engels EA, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion. 2003;43:1260–1268
  16. Ferreira S, Sanabani S, Reis AD, et al. Human herpesvirus type 8 among Brazilian blood donors. Transfusion. 2003;43:1764–1765
  17. Belec L, Cancre N, Hallouin MC, et al. High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8. Transfusion. 1998;38:771–775
  18. Enbom M, Urassa W, Massambu C, et al. Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission. J Med Virol. 2002;68:264–267
  19. Hudnall SD, Chen T, Rady P, et al. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion. 2003;43:85–90
  20. Mbulaiteye SM, Biggar RJ, Bakaki PM, et al. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst. 2003;95:1330–1335
  21. Cottoni F, Santarelli R, Gentile G, et al. High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy. J Clin Virol. 2004;30:106–109
  22. Lefrere JJ, Mariotti M, Girot R, et al. Transfusional risk of HHV-8 infection. Lancet. 1997;350:217
  23. Marcelin AG, Apetrei C, Dupin N, et al. Parenteral transmission of Kaposi's sarcoma-associated herpesvirus. AIDS. 1998;12:2351
  24. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med. 2001;344:637–643
  25. Goedert JJ, Charurat M, Blattner WA, et al. Risk factors for Kaposi's sarcoma-associated herpes virus infection among HIV-1-infected pregnant women in the USA. AIDS. 2003;17:425–433
  26. Bagni R, Whitby D. Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Curr Opin HIV AIDS. 2009;4:22–26
  27. Operskalski EA, Busch MP, Mosley JW, et al. Blood donations and viruses. Lancet. 1997;349:1327
  28. Engels EA, Eastman H, Ablashi DV, et al. Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst. 1999;91:1773–1775
  29. Dollard SC, Nelson KE, Ness PM, et al. Possible transmission of human herpesvirus 8 by blood transfusion in a historical United States cohort. Transfusion. 2005;45:500–503
  30. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med. 2006;355:1331–1338
  31. Cannon MJ, Operskalski EA, Mosley JW, et al. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical United States cohort. J Infect Dis. 2009;199:1592–1598
  32. Dodd RY. Human herpesvirus 8: What (not) to do?. Transfusion. 2005;45:463–465
  33. Blajchman MA, Vamvakas EC. The continuing risk of transfusion-transmitted infections. N Engl J Med. 2006;355:1303–1305
  34. Lefrere JJ, Guillaume N, Laperche S. Should cellular therapy products be tested for human herpesvirus 8?. Transfusion. 2007;47:1550
  35. Moore PS, Chang Y, Jaffe HW. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med. 2007;356:88
  36. Busch M, Glynn S. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: The National Heart, Lung, and Blood Institute Biologic Specimen Repository. J Infect Dis. 2009;199:1564–1566
  37. de Souza VA, Sumita LM, Nascimento MC, et al. Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis. 2007;196:844–852
  38. Biggar RJ, Whitby D, Marshall V, et al. Human herpesvirus 8 in Brazilian Amerindians: A hyperendemic population with a new subtype. J Infect Dis. 2000;181:1562–1568
  39. Mohanna S, Maco V, Bravo F, et al. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: A critical review of an old disease. Int J Infect Dis. 2005;9:239–250
  40. Alkharsah KR, Dedicoat M, Blasczyk R, et al. Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis. 2007;195:809–816
  41. Whitby D, Marshall VA, Bagni RK, et al. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Int J Cancer. 2007;120:321–328
  42. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, et al. Water, socioeconomic factors, and human herpesvius 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr. 2005;38:474–479
  43. Whitby D, Luppi M, Sabin C, et al. Detection of antibodies to human herpesvirus 8 in Italian children: Evidence of horizontal transmission. Br J Cancer. 2000;82:702–704
  44. Malope BI, Pfeiffer RM, Mbisa G, et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr. 2007;44:351–355
  45. Minhas V, Crabtree KL, Chao A, et al. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol. 2008;168:311–320
  46. Mbulaiteye SM, Pfeiffer RM, Dolan B, et al. Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis. 2008;14:586–591
  47. Bourboulia D, Whitby D, Boshoff C, et al. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA. 1998;280:31–32
  48. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer. 1998;77:817–820
  49. Angeloni A, Heston L, Uccini S, et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis. 1998;177:1715–1718
  50. Plancoulaine S, Abel L, van Beveren M, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000;356:1062–1065
  51. Brayfield BP, Kankasa C, West JT, et al. Distribution of Kaposi-sarcoma associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: Implications for transmission. J Infect Dis. 2004;189:2260–2270
  52. Mantina H, Kankasa C, Klaskala W, et al. Vertical transmission of Kaposi's sarcoma-associated herpesvirus. Int J Cancer. 2001;94:749–752
  53. Martro E, Bultreys M, Stewart JA, et al. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol. 2004;72:126–131
  54. Mbulaiteye SM, Pfeiffer RM, Whitby D, et al. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis. 2003;187:1780–1785
  55. Plancoulaine S, Abel L, Trégouët D, et al. Respective roles of serological status and blood specific antihuman herpesvirus-8 antibody levels in human herpesvirus-8 intrafamilial transmission in a highly endemic area. Cancer Res. 2004;64:8782–8787
  56. Mbulaiteye S, Marshall V, Bagni RK, et al. Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis. 2006;193:1250–1257
  57. Dukers NHTM, Rezza G. Human herpesvirus 8 epidemiology: What we do and do not know. AIDS. 2003;17:1717–1730
  58. Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus-8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis. 2007;196:199–207
  59. Malope BI, MacPhail P, Mbissa G, et al. No evidence of sexual transmission of Kaposi's sarcoma herpesvirus in a heterosexual South African population. AIDS. 2008;22:519–526
  60. Martin JN, Ganen DE, Osmond DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338:948–954
  61. Smith NA, Sabin CA, Gopal R, et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual men. J Infect Dis. 1999;180:600–606
  62. Martin JN, Osmond DH. Determining specific sexual practices associated with human herpesvirus 8 transmission. Am J Epidemiol. 2000;151:225–229
  63. Grulich AE, Cunningham P, Munier ML, et al. Sexual behavior and human herpesvirus infection in homosexual men in Australia. Sex Health. 2005;2:13–18
  64. Martro E, Esteve A, Schultz TF, et al. Risk factors for human herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicenter study. Int J Cancer. 2007;120:1129–1135
  65. Belec L, Tevi-Benissan C, Mohamed AS, et al. Enhanced detection of human herpesvirus 8 and cytomegalovirus in semen of HIV-seropositive asymptomatic heterosexual men living in Central Africa. AIDS. 1998;12:674–676
  66. Taylor MM, Chohan B, Lavreys L, et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and seronegative Kenyan women. J Infect Dis. 2004;190:484–488
  67. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343:1369–1377
  68. Martin JN. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin Hematol. 2003;40:133–142
  69. Atkinson J, Edlin BR, Engels EA, et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis. 2003;187:974–981
  70. Jenkins FJ, Hoffman LJ, Liegey-Dougall A. Reactivation of and primary infection with human herpesvirus-8 among solid-organ transplant recipients. J Infect Dis. 2002;185:1238–1243
  71. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus 8 in transplant patients. Blood. 2000;96:3279–3281
  72. Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi's sarcoma lesions from renal transplant recipients barcoded either genetic or antigenic markers of the matched donors. Nat Med. 2003;9:554–561
  73. Pfeiffer RM, Mbulaiteye S, Engels E. A model to estimate risk of infection with human herpesvirus 8 associated with transfusion from cross-sectional data. Biometrics. 2004;60:249–256
  74. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990;12(Suppl. 7):S701–S710
  75. Adler SP, McVoy MM. Cytomegalovirus infections in seropositive patients after transfusion: The effect of red-cell storage and volume. Transfusion. 1989;29:667–671
  76. Roujeau JC, Brun-Buisson C, Penso D, et al. Non-acquired immune deficiency syndrome-related Kaposi's sarcoma after severe infection. J Am Acad Dermatol. 1988;18:378
  77. Friedman Kien AE, Saltzman BR, Cao Y, et al. Kaposi's sarcoma in HIV-negative homosexual men. Lancet. 1990;355:168–169
  78. Bendsoe N, Dictor M, Blomberg J, et al. Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic. Eur J Cancer. 1990;26:699–702
  79. Velez-Garcia E, Robles-Cardona N, Fradera J. Kaposi's sarcoma in transfusion-associated AIDS. N Engl J Med. 1985;312:648
  80. Cockerill FR, Hurley D, Miglagelada JR. Polymicrobial cholangitis and Kaposi's sarcoma in blood product transfusion-related acquired immune deficiency syndrome. Am J Med. 1986;80:1237–1241
  81. Padilla S, Rivera-Perlman Z, Solomon L. Kaposi's sarcoma in transfusion-related acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1990;114:40–42
  82. Aboulafia D, Mathisen G, Mitsuyasu R. Case-report: Aggressive Kaposi's sarcoma and Campylobacter bacteremia in a female with transfusion-associated AIDS. Am J Med Sci. 1991;301:256–258
  83. Vamvakas E. Why are men who have had sex with men even once since 1977 indefinitely deferred from donating blood?. Transfusion. 2009;49:1037–1042
  84. Vamvakas EC. Scientific background on the risk engendered by reducing the lifetime blood donation deferral period for men who have sex with men. Transf Med Rev. 2009;23:85–102
  85. Qu L, Xu S, Rowe D, et al. Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells. Transfusion. 2005;45:591–595
  86. Alfieri C, Tanner J, Carpenter L, et al. EBV transmission from a blood donor to an organ-transplant recipient with recovery of the same virus strain from the recipient blood and oropharynx. Blood. 1996;87:812–817
  87. Tattevin P, Cremieux AC, Descamps D, et al. Transfusion-related infectious mononucleosis. Scand J Infect Dis. 2002;34:777–778
  88. Pearson HA, Wood C, Andeman W, et al. Low risk of hepatitis B from blood transfusions in thalassemic patients in Connecticut. J Pediatr. 1986;108:252–253
  89. Papaevangelou G, Economidou J, Roumeliotou A, et al. Epstein-Barr infection in polytransfused patients with homozygous beta-thalassemia. Vox Sang. 1979;37:305–309
  90. Henle W, Henle G. Epstein-Barr virus and blood transfusions. In:  Dodd RY,  Barker LF editor. Infection, Immunity, and Blood Transfusion. New York, NY: Alan R. Liss; 1985;p. 201–209

PII: S0887-7963(09)00081-9

doi: 10.1016/j.tmrv.2009.09.001

Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 1-14 , January 2010

Article Tools

* Image Usage & Resolution